GCP Compliance and Managing Clinical Trials during Covid-19

GCP Compliance and Managing Clinical Trials during Covid-19

This course will with a brief overview of complying with GCP, then moving onto discussing how Covid-19 has impacted the way Clinical Trials are being managed. This included discussing challenges with patient safety and Investigational Medicinal Products (IMPs). We also looked at how the regulations from the European Medicines Agency, MHRA and the US Food and Drug Administration have been impacted by these changes.

An overview of complying with GCP and discussion of how Covid-19 has impacted the management of Clinical Trials.

Url: View Details

What you will learn

• This course will begin with a brief introduction to compliance with Good Clinical Practice (GCP). The second part will focus on managing Clinical Trials with restrictions and uncertainties brought about by Covid-19.

Rating: 4.2

Level: Intermediate Level

Duration: 1 hour

Instructor: Linda Hopkinson